Management of cancer patients with oral therapy at home in Brittany and Pays de la Loire areas: Survey (end of 2016) and cartography

被引:3
作者
Grude, Francoise [1 ]
Marhuenda, Fanny [1 ]
Deniel-Lagadec, Delphine [1 ,2 ]
Bessard, Rejane [3 ]
Pracht, Marc [4 ]
Bourgeois, Hugues [5 ]
Kowalski, Dominique Carlhant [6 ]
Metges, Jean-Philippe [2 ]
Vidal, Anne Marie [7 ]
Ganem, Gerard [5 ]
机构
[1] Coordinat ICO Paul Papin, Observ Dedie Canc Bretagne Pays Loire OMEDIs Bret, 15 Rue Andre Boquel, F-49000 Angers, France
[2] CHRU Brest, Site Morvan 5,Ave Foch, F-29609 Brest, France
[3] CH Bretagne Atlantique, 20 Blvd Gen Maurice Guillaudot, F-56017 Vannes, France
[4] CRLCC Eugene Marquis, Ave Bataille Flandres Dunkerque, F-35000 Rennes, France
[5] Ctr Jean Bernard, Clin Victor Hugo, 18 Rue Victor Hugo, F-72000 Le Mans, France
[6] CHRU Brest, La Cavale Blanche, Blvd Tanguy Prigent, F-29200 Brest, France
[7] CH Le Mans, 194 Ave Rubillard, F-72037 Le Mans 9, France
关键词
Survey; Oral Anti-cancer Drug (OAD); Map; Care management; Organization; Hospital-city link; MEDICATION ADHERENCE; AGENTS; CHEMOTHERAPY; SAFETY;
D O I
10.1016/j.bulcan.2019.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction > The Cancer Observatory, from the OMEDITs (Observatory for Medicines and Medical Devices and Treatment Innovations) of Bretagne and Pays de la Loire areas has conducted a survey aiming to know and map the current practices of management of patients by Oral Anticancer Drug (OAD) in inter-region. Methods > Forty eight cancer centers received by e-mail in July and October 2016 a questionnaire concerning the management of OADs : from prescription by the specialist of oncology, to the intervention of the pharmacist (analysis and pharmaceutical consulting), to follow-up by nurse, as well as the financing of this activity and the feelings of the actors about this organizational set up. Results > Fifty-seven professionals from 31 centers, including the most important ones, responded to the survey. As a result, half of the establishments carry out a pharmaceutical analysis for some or all of the OAD prescriptions and only 30% carry out a pharmaceutical consulting. The nurse consultation is, on the other hand, more largely implanted (74% of the centers) as well as the telephone follow-up (6%). More than 90% of professionals believe that the organizational set up could be improved and more secure by, at least, the stronger involvement of pharmacists, the development of tools for nurse (for monitoring, therapeutic education...) and by improving the city-hospital link. Conclusion > This survey shows the variability in the management of patients under OAD because of the lack of resources to ensure the fairness and sustainability of the organizational set up. The hospital/city link could still be optimized to secure patient care.
引用
收藏
页码:847 / 859
页数:13
相关论文
共 21 条
[1]  
[Anonymous], 2015, PLAN CANC 3 GUERIR P
[2]  
Birner Ann, 2003, Clin J Oncol Nurs, V7, P158, DOI 10.1188/03.CJON.158-162
[3]   Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin:: a randomised crossover trial in advanced colorectal cancer [J].
Borner, MM ;
Schöffski, P ;
de Wit, R ;
Caponigro, F ;
Comella, G ;
Sulkes, A ;
Greim, G ;
Peters, GJ ;
van der Born, K ;
Wanders, J ;
de Boer, RF ;
Martin, C ;
Fumoleau, P .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (03) :349-358
[4]  
Bourbouloux E, 2017, J ONCOGERIATR, V8, P5
[5]   Comparative adherence to oral hormonal agents in older women with breast cancer [J].
Cheung, Winson Y. ;
Lai, Edward Chia-Cheng ;
Ruan, Jenny Y. ;
Chang, Jennifer T. ;
Setoguchi, Soko .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (02) :419-427
[6]   Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer [J].
Conroy, T. ;
Hebbar, M. ;
Bennouna, J. ;
Ducreux, M. ;
Ychou, M. ;
Lledo, G. ;
Adenis, A. ;
Faroux, R. ;
Rebischung, C. ;
Kockler, L. ;
Douillard, J. Y. .
BRITISH JOURNAL OF CANCER, 2010, 102 (01) :59-67
[7]  
HAS, 2018, METTR OEUVR CONC TRA
[8]   Medication non-adherence in the elderly - How big is the problem? [J].
Hughes, CM .
DRUGS & AGING, 2004, 21 (12) :793-811
[9]  
Institut national du cancer (INCA), 2016, Parcours de soins d'un patient traite par anticancereux oraux. Reponse saisine
[10]  
Institut National du Cancer (INCA), 2015, CHIM OR CANC 2014